Tekla Healthcare Investors (NYSE:HQH) was the recipient of a significant decline in short interest in the month of May. As of May 14th, there was short interest totalling 11,500 shares, a decline of 78.2% from the April 29th total of 52,800 shares. Based on an average daily volume of 156,100 shares, the days-to-cover ratio is presently 0.1 days.
A number of institutional investors have recently bought and sold shares of the business. D Orazio & Associates Inc. acquired a new stake in shares of Tekla Healthcare Investors in the 1st quarter valued at approximately $25,000. Lindbrook Capital LLC purchased a new stake in shares of Tekla Healthcare Investors in the fourth quarter valued at $60,000. Northwest Investment Counselors LLC acquired a new position in Tekla Healthcare Investors in the first quarter valued at $74,000. RMR Wealth Builders boosted its holdings in Tekla Healthcare Investors by 300.6% in the first quarter. RMR Wealth Builders now owns 3,637 shares of the financial services provider’s stock valued at $89,000 after acquiring an additional 2,729 shares during the last quarter. Finally, Centaurus Financial Inc. acquired a new position in shares of Tekla Healthcare Investors during the fourth quarter worth about $107,000. 20.16% of the stock is owned by institutional investors.
Shares of HQH traded down $0.45 during trading hours on Thursday, hitting $24.27. 2,242 shares of the stock were exchanged, compared to its average volume of 150,757. The stock’s 50-day moving average price is $24.33 and its two-hundred day moving average price is $23.82. Tekla Healthcare Investors has a 12-month low of $19.43 and a 12-month high of $26.01.
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 30th. Stockholders of record on Friday, May 28th will be issued a $0.50 dividend. The ex-dividend date is Thursday, May 27th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 8.24%.
About Tekla Healthcare Investors
Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.
Featured Article: How Do Mutual Funds Work?